GALT
Closed
Galectin Therapeutics Inc
2.23
+0.12 (+5.69%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 2.11
Day's Range: 2.1 - 2.27
Send
sign up or login to leave a comment!
When Written:
2.0501
Galectin Therapeutics Inc. is a biotechnology company that focuses on the development of therapies for fibrotic diseases and cancer. The company's lead product candidate is GR-MD-02, a galectin-3 inhibitor, which is being developed for the treatment of liver fibrosis and fatty liver disease. The company is also developing other galectin inhibitors for the treatment of cancer and other fibrotic diseases. Galectin Therapeutics Inc. was founded in 2000 and is headquartered in Norcross, Georgia.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








